Return your empty ink cartridges to us and together, let us picture a greener nation.
Find a drop-off center near you:
04 May 2020 — In order to stop the spread of COVID-19, there is an urgent need for business, government and academia to overcome existing barriers and join forces, free from established mindsets, to accelerate development and manufacturing in such fields as therapeutic drugs, vaccines, medical devices and infection control products. Entities who become signatories of the COVID-19 Countermeasure Declaration pledge that they will not assert their patents, utility models, designs or copyrights during the time of this crisis against any activities whose purpose is stopping the spread of COVID-19, including diagnosis, prevention, containment and treatment. By eliminating the need for complicated, time-consuming analysis of intellectual property rights of the declarers and license negotiations for such intellectual property rights, this declaration clears the way for the fastest possible means of research, development and manufacture of the most effective tools to combat the spread of COVID-19. A large number of entities possessing substantial patent portfolio and industry organizations have joined the declaration in response to the invitation by Professor Fumihiko Matsuda of Kyoto University and Canon. The founding members of the declaration welcome other intellectual property rights owners to join them and further contribute to the goal of halt the spread of COVID-19. IP OPEN ACCESS DECLARATION AGAINST COVID-19 website: https://www.gckyoto.com/covid-2Read More
26 Mar 2020 — Canon Medical Systems Corporation (Headquarters: Otawara, Tochigi Prefecture, Japan; President and CEO: Toshio Takiguchi), working together with Nagasaki University, has completed development of Genelyzer KIT 1 a set of reagents for SARS-CoV-2 RNA testing based on a gene amplification technique known as the fluorescent LAMP method. 2 The results of validation of the rapid genetic testing system employing this technique were released in a report titled "Validation of 2019-nCoV gene testing method in which clinical evaluation results were obtained using clinical specimens" 3 issued on March 26, 2020, by the Ministry of Health, Labour and Welfare and the National Institute of Infectious Diseases of Japan. This report showed a specificity of 100% and a sensitivity of 90% or more. Based on an administrative notification issued by the Ministry of Health, Labour and Welfare, 4 the rapid genetic testing system has been granted approval for practical application in government-conducted testing. In positive specimens, the testing system can detect 15 or more viral genome copies per reaction within approximately 10 minutes with 100% sensitivity. The entire test procedure, from preprocessing the sample to obtaining the test results, can be completed in as little as 40 minutes, which is much less than the time required for conventional genetic testing methods. In order to take full advantage of the testing system's rapid testing capabilities, Canon Medical Systems Corporation will continue evaluating its practical application in public health protection and border control measures at clinical sites, airports, and other locations where testing needs to be completed on the same day. This research project is part of a research program focusing on risk evaluation of emerging and re-emerging infectious diseases and the implementation of emergency management functions which is being conducted under Health and Labour Science Research Grants. Together with Nagasaki University, Canon Medical Systems Corporation is participating in a research project on the practical application of rapid genetic testing systems led by the Japan Agency for Medical Research and Development (AMED) and has been working on the development of this testing system since receiving a request for cooperative development of a testing system from the National Institute of Infectious Diseases of Japan in February 2020. The testing system has now quickly entered the practical application phase under the framework of industry-academia-government collaboration with the support of the Ministry of Health, Labour and Welfare of Japan and other involved parties. Canon Medical Systems Corporation hopes that the testing system will be used at a wide range of clinical sites in Japan to help control the spread of coronavirus disease 2019 (COVID-19). At the same time, our goal is to contribute to the development of effective measures against the spread of infectious diseases in all parts of the world using this rapid genetic testing system developed in Japan. 1 This testing system makes it possible to quickly detect a novel coronavirus gene in patient specimens. The entire procedure, including extraction of the viral genome prior to testing, can be completed in a short time of 40 minutes or less. Due to the light weight, compact design, and ease of operation of the testing system, it is suitable for use at a wide range of clinical sites, including remote locations such as isolated islands. 2 A nucleic acid amplification method known as LAMP (loop-mediated isothermal amplification) developed by Eiken Chemical Co., Ltd. 3 https://www.niid.go.jp 4 Administrative notification issued on March 18, 2020, by the Tuberculosis and Infectious Diseases Control Division, Health Services Bureau, Ministry of Health, Labour and Welfare of Japan (Method for 2019-nCoV gene testing in government-conducted testing)
13 Feb 2020 — Canon announced that the company is currently developing the EOS R5 full-frame mirrorless camera—containing CMOS sensor, image processing, optical and other state-of-the-art technologies the company has cultivated through its long history of camera development. In line with this, Canon plans to release a total of 9 RF lenses currently in development over the course of 2020. Through the addition of competitive cameras and lenses to its lineup, Canon will continue to strengthen the EOS R System. The EOS R System enables greater freedom in lens design thanks to a wider lens mount diameter, short back focus and high-speed system for transmitting data between the camera and lens, resulting in an imaging system that delivers higher image quality and greater ease-of-use. The new full-frame mirrorless camera currently under development will fully leverage the advantages of the EOS R System to realize high-speed continuous shooting, 8K video recording and expanding the boundaries of visual expression. In addition, it can contribute to more efficient workflows thanks to improved transmission functionality, operability and reliability. These enhancements and more will help the new camera elevate the EOS Series concept of “Speed, Comfort and High image-quality” to a higher level. Canon’s EOS R5, the first of the next-generation full-frame mirrorless cameras in the company’s EOS R System, will include a newly developed CMOS sensor that makes possible advanced features such as high-speed continuous shooting – up to approximately 20 frames per second (FPS) using an electronic shutter and up to approximately 12 FPS using a mechanical shutter – to facilitate shooting of athletes at sporting events and other fast-moving subjects. In addition, the camera’s 8K video capture capability will enable users to extract high-resolution still images from video footage as well as process 8K video into higher-quality 4K videos, opening up new possibilities for visual expression. What’s more, the EOS R5 will be the first Canon camera equipped with a high-performance coordinated Image Stabilization (IS) system that integrates the camera’s in-body IS with IS systems on attached RF lenses. The camera will also feature dual media card slots and support automatic transfers of image files from the device to the image.canon cloud platform. In line with customers’ needs, Canon is also pleased to launch the RF24-105mm f/4-7.1 IS STM, the smallest and lightest RF zoom lens available to date and weighing only 395g with a length of 88.8mm. Reasonably priced and available as a kit lens for EOS R and EOS RP, the RF24-105mm f/4-7.1 IS STM offers an affordable option for users who wish to jump into the full-frame bandwagon by adopting the new EOS R system. When utilized with the renowned RF mount, the RF24-105mm f/4-7.1 IS STM will deliver top-notch image quality. Coupled with Image Stabilization of up to five stops, capturing images in challenging lighting conditions will be a breeze. Another unique feature of the RF24-105mm f/4-7.1 IS STM is its ability to take excellent close-up images. With up to 0.4x magnification, capturing fine details of tiny objects is easily achieved. 0.5x magnification is also possible in Manual Focus mode for users looking to get more close-up images of their subjects. Alongside the EOS R5, Canon is also developing a total of 9 RF lenses scheduled for release during 2020, including the RF100-500mm f/4.5-7.1L IS USM, Extender RF 1.4x and Extender RF 2x.
28 Feb 2020 — In line with its corporate philosophy of Kyosei, which enjoins all people to live and work together for the common good into the future, Canon’s four companies in the Philippines and their staff have pledged a total of PHP290,000 to the Philippine Red Cross. This donation is dedicated to Filipinos affected by the Taal volcanic eruption. “Canon Philippines has always been an advocate of spreading delight even beyond the industry and we want to take part in helping Taal volcanic eruption victims the best way we can,” says Kazuhiro Ozawa, President & CEO of Canon Philippines. “We hope that our donation will aid those that were greatly affected by the calamity.” he adds. Aside from the monetary donation by the companies, their employees also contributed to the cause. Canon Business Service Centre Philippines, Inc. staff sent relief goods, Canon Marketing (Philippines), Inc. staff shared preloved clothes, while staff of Canon Business Machines Philippines, Inc., located in Batangas, pooled money to help their neighboring communities. The Philippine Institute of Volcanology and Seismology reports ongoing quakes in the area and has not lowered the alert level below 2, indicating continuous albeit decreased, volcanic activity. A total of 16,000 homeless and unemployed families have been reported by the Philippine Red Cross. While tent cities have been built, offering evacuees some privacy and communal facilities like kitchens and toilets, the government and NGOs are still looking for more permanent options for the displaced people. Asked if there were plans victims could look forward to, Jewel Macatangay, Business Development Manager at the Philippine Red Cross said the PRC is presently looking for land donations and alternative means of livelihood. “Recovery will take years. We are thankful to those who remember and continue to help long after the dust has settled”